Cargando…
Doxorubicin combined with Notch1-targeting siRNA for the treatment of gastric cancer
Notch1, a transmembrane receptor that has a notable role in gastric cancer (GC) as an oncogene, has been reported to be involved in doxorubicin resistance. Thus, Notch1 is a potential therapeutic target for GC. In the present study, the protein levels of Notch1 intracellular domain (NICD; a marker o...
Autores principales: | Zhou, Wei, Tan, Wei, Huang, Xu, Yu, Hong Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096196/ https://www.ncbi.nlm.nih.gov/pubmed/30127866 http://dx.doi.org/10.3892/ol.2018.9039 |
Ejemplares similares
-
Doxorubicin-conjugated siRNA lipid nanoparticles for combination cancer therapy
por: Butowska, Kamila, et al.
Publicado: (2023) -
Synergistic treatment of osteosarcoma with biomimetic nanoparticles transporting doxorubicin and siRNA
por: Zhao, Jingtong, et al.
Publicado: (2023) -
Downregulation of STAT3, β-Catenin, and Notch-1 by Single and Combinations of siRNA Treatment Enhance Chemosensitivity of Wild Type and Doxorubicin Resistant MCF7 Breast Cancer Cells to Doxorubicin
por: Alshaer, Walhan, et al.
Publicado: (2019) -
Galactosylated Liposomes for Targeted Co-Delivery of Doxorubicin/Vimentin siRNA to Hepatocellular Carcinoma
por: Oh, Hea Ry, et al.
Publicado: (2016) -
Targeted Delivery of siRNA
por: Oliveira, Sabrina, et al.
Publicado: (2006)